On August 15, 2022, MIT Technology Review features insights from AFAR grantee Matt Kaeberlein, PhD. Dr. Kaeberlein discusses how the Dog Aging Project – co-led by Kaeberlein and 1998 and 2010 AFAR Grantee Daniel Promislow, PhD – is helping advance the field's understanding of therapeutics that target the biological processes of aging to extend healthspan.
Dr. Kaeberlein is a 2006 Glenn Foundation for Medical Research and AFAR Grants for Junior Faculty recipient, and a 2007 Glenn Foundation for Medical Research Breakthroughs in Gerontology (BIG) Award recipient. He is also the Co-Director at the University of Washington Nathan Shock Center of Excellence in the Basic Biology of Aging, the Director of the Healthy Aging and Longevity Research Institute, the President of the American Aging Association, the Co-Director of the Dog Aging Project, and a Professor at the University of Washington.
Read the article, “These Scientists Are Working to Extend the Life Span of Pet Dogs – and Their Owners,” here.
For more on the Dog Aging Project, watch AFAR's Live Better Longer webinar featuring Dr. Kaeberlein here.
